Skyhawk Therapeutics' Pre-Seed Round

Skyhawk Therapeutics raised a round of funding on September 25, 2017. Investors include Good Growth Capital.

Skyhawk Therapeutics, fka Rare Genetix, is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.…

Articles about Skyhawk Therapeutics' Pre-Seed Round: